References
- Adler Y, Charron P, et al. 2015 esc guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the european society of cardiology (esc)endorsed by: the european association for cardio-thoracic surgery (eacts). Eur Heart J. 2015;36(42):2921–2964.
- Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet. 2004;363(9410):717–727.
- Roberts WC. Pericardial heart disease: its morphologic features and its causes. Proceedings(Bayl Univ Med Cent). 2005;18(1):38–55.
- Freeman GL, Lewinter MM. Pericardial adaptations during chronic cardiac dilation in dogs. Circ Res. 1984;54(3):294–300.
- Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation. 2010;121(7):916–928.
- Klein AL, Abbara S, Agler DA, et al. American society of echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the society for cardiovascular magnetic resonance and society of cardiovascular computed tomography. J Am Soc Echocardiogr. 2013;26(9):965–1012 e1015.
- Fruergaard P, Launbjerg J, Hesse B, et al. The diagnoses of patients admitted with acute chest pain but without myocardial infarction. Eur Heart J. 1996;17(7):1028–1034.
- Zayas R, Anguita M, Torres F, et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol. 1995;75(5):378–382.
- Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112(23):3608–3616.
- Reuter H, Burgess LJ, Doubell AF. Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect. 2005;133(3):393–399.
- Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases: part ii: noninfectious pericarditis, pericardial effusion and constrictive pericarditis. J Cardio Vasc Med. 2010;11(11):785–794.
- Thienemann F, Sliwa K, Rockstroh JK. HIV and the heart: the impact of antiretroviral therapy: A global perspective. Eur Heart J. 2013;34(46):3538–3546.
- Imazio M, Demichelis B, Cecchi E, et al. Cardiac troponin i in acute pericarditis. J Am Coll Cardiol. 2003;42(12):2144–2148.
- Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J. Primary acute pericardial disease: A prospective series of 231 consecutive patients. Am J Cardiol. 1985;56(10):623–630.
- Little WC, Freeman GL. Pericardial disease. Circulation. 2006;113(12):1622–1632.
- Ariyarajah V, Spodick DH. Acute pericarditis: diagnostic cues and common electrocardiographic manifestations. Cardiol Rev. 2007;15(1):24–30.
- Spodick DH. Acute pericarditis: current concepts and practice. JAMA. 2003;289(9):1150–1153.
- Wang K, Asinger RW, Marriott HJL. St-segment elevation in conditions other than acute myocardial infarction. N Eng J Med. 2003;349(22):2128–2135.
- Leitman M, Bachner-Hinenzon N, Adam D, et al. Speckle tracking imaging in acute inflammatory pericardial diseases. Echocardiography. 2011;28(5):548–555.
- Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115(21):2739–2744.
- O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 accf/aha guideline for the management of st-elevation myocardial infarction: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation. 2013;127(4):e362–425.
- Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the colchicine for acute pericarditis (cope) trial. Circulation. 2005;112(13):2012–2016.
- Lotrionte M, Biondi-Zoccai G, Imazio M, et al. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J. 2010;60(4):662–670.
- Artom G, Koren-Morag N, Spodick DH, et al. Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: A multi-centre all-case analysis. Eur Heart J. 2005;26(7):723–727.
- Augustin P, Desmard M, Mordant P, et al. Clinical review: Intrapericardial fibrinolysis in management of purulent pericarditis. Crit Care. 2011;15(2):220.
- Mayosi BM, Ntsekhe M, Bosch J, et al. Prednisolone and mycobacterium indicus pranii in tuberculous pericarditis. N Eng J Med. 2014;371(12):1121–1130.
- Imazio M, Demichelis B, Parrini I, et al. Day-hospital treatment of acute pericarditis: A management program for outpatient therapy. J Am Coll Cardiol. 2004;43(6):1042–1046.
- Imazio M, Brucato A, Maestroni S, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation. 2011;124(11):1270–1275.
- Imazio M, Brucato A, Barbieri A, et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation. 2013;128(1):42–49.
- Imazio M, Trinchero R, Shabetai R. Pathogenesis, management, and prevention of recurrent pericarditis. J Card Vasc Med. 2007;8(6):404–410.
- Imazio M, Demichelis B, Parrini I, et al. Management, risk factors, and outcomes in recurrent pericarditis. Am J Cardiol. 2005;96(5):736–739.
- Cantarini L, Lopalco G, Selmi C, et al. Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis. Autoimmun Rev. 2015;14(2):90–97.
- Maestroni S, Di Corato PR, Cumetti D, et al. Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev. 2012;12(1):60–65.
- Lilly LS. Treatment of acute and recurrent idiopathic pericarditis. Circulation. 2013;127(16):1723–1726.
- Imazio M, Brucato A, Cemin R, et al. Colchicine for recurrent pericarditis (corp): a randomized trial. Ann Intern Med. 2011;155(7):409–414.
- Imazio M, Bobbio M, Cecchi E, et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the core (colchicine for recurrent pericarditis) trial. Arch Intern Med. 2005;165(17):1987–1991.
- Raval J, Nagaraja V, Eslick GD, et al. The role of colchicine in pericarditis - a systematic review and meta-analysis of randomised trials. Heart, Lung Circ. 2015;24(7):660–666.
- Scott IC, Hajela V, Hawkins PN, et al. A case series and systematic literature review of anakinra and immunosuppression in idiopathic recurrent pericarditis. J Cardiol Cases. 2011;4(2):e93–e97.
- Marcolongo R, Russo R, Laveder F, et al. Immunosuppressive therapy prevents recurrent pericarditis. J Am Coll Cardil. 1995;26(5):1276–1279.
- Finetti M, Insalaco A, Cantarini L, et al. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. J Pediatr. 2014;164(6):1425–1431 e1421.
- Khandaker MH, Schaff HV, Greason KL, et al. Pericardiectomy vs medical management in patients with relapsing pericarditis. Mayo Clin Proc. 2012;87(11):1062–1070.
- Imazio M, Brucato A, Adler Y, et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. Am J Cardiol. 2007;100(6):1026–1028.
- Bertog SC, Thambidorai SK, Parakh K, et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol. 2004;43(8):1445–1452.
- Schwefer M, Aschenbach R, Heidemann J, et al. Constrictive pericarditis, still a diagnostic challenge: comprehensive review of clinical management. Eur J Cardiothorac Surg. 2009;36(3):502–510.
- Tettey M, Sereboe L, Aniteye E, et al. Surgical management of constrictive pericarditis. Ghana Med J. 2007;41(4):190–193.
- Talwar KK, Narula JP, Chopra P. Myocarditis and myocardial interstitial fibrosis in constrictive pericarditis–an extended pathological spectrum? Int J Cardiol. 1990;29(2):241–243.
- Greenwood RD, Rosenthal A, Cassady R, et al. Constrictive pericarditis in childhood due to mediastinal irradiation. Circulation. 1974;50(5):1033–1039.
- Cremer PC, Kwon DH. Multimodality imaging of pericardial disease. Curr Cardiol Rep. 2015;17(4):24.
- Talreja DR, Edwards WD, Danielson GK, et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation. 2003;108(15):1852–1857.
- Talreja DR, Nishimura RA, Oh JK, et al. Constrictive pericarditis in the modern era: novel criteria for diagnosis in the cardiac catheterization laboratory. J Am Coll Cardiol. 2008;51(3):315–319.
- Nishimura RA, Carabello BA. Hemodynamics in the cardiac catheterization laboratory of the 21st century. Circulation. 2012;125(17):2138–2150.
- Ling LH, Oh JK, Schaff HV, et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999;100(13):1380–1386.
- Galve E, Garcia-Del-Castillo H, Evangelista A, et al. Pericardial effusion in the course of myocardial infarction: incidence, natural history, and clinical relevance. Circulation. 1986;73(2):294–299.
- Pepi M, Muratori M, Barbier P, et al. Pericardial effusion after cardiac surgery: incidence, site, size, and haemodynamic consequences. Br Heart J. 1994;72(4):327–331.
- Corey GR, Campbell PT, Van Trigt P, et al. Etiology of large pericardial effusions. Am J Med. 1993;95(2):209–213.
- Guberman BA, Fowler NO, Engel PJ, et al. Cardiac tamponade in medical patients. Circulation. 1981;64(3):633–640.
- Trautner BW, Darouiche RO. Tuberculous pericarditis: optimal diagnosis and management. Clin Infect Dis. 2001;33(7):954–961.
- El Haddad D, Iliescu C, Yusuf SW, et al. Outcomes of cancer patients undergoing percutaneous pericardiocentesis for pericardial effusion. J Am Coll Cardiol. 2015;66(10):1119–1128.
- Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013;34(16):1186–1197.
- Beck CS. Two cardiac compression triads. JAMA. 1935;104(9):714–716.
- Roy CL, Minor MA, Brookhart M, et al. Does this patient with a pericardial effusion have cardiac tamponade? JAMA. 2007;297(16):1810–1818.
- Bilchick KC, Wise RA. Paradoxical physical findings described by kussmaul: pulsus paradoxus and kussmaul’s sign. Lancet. 2002;359(9321):1940–1942.
- Argula RG, Negi SI, Banchs J, et al. Role of a 12-lead electrocardiogram in the diagnosis of cardiac tamponade as diagnosed by transthoracic echocardiography in patients with malignant pericardial effusion. Clin Cardiol. 2015;38(3):139–144.